Therapeutics: Hemoglobin subunit γ 1 (HBG1); HBG2; CRISPR-associated protein 9 (Cas9)

Hematology

INDICATION: Sickle cell disease (SCD)

Patient sample and cell culture studies suggest enhancing

Read the full 123 word article

User Sign In